Trial Information
Current as of June 06, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the safety and effectiveness of a medication called Lorbrena for patients with non-small cell lung cancer. The researchers want to learn more about how this drug affects the brain and whether it can cause any liver problems when taken alongside other specific medications. They are currently looking for participants and have no age or gender restrictions, meaning anyone who has received Lorbrena can join.
If you decide to participate, you will be part of a study that aims to gather important information that could help improve treatment for others in the future. There are no specific health issues that would exclude you from this trial, so if you've been treated with Lorbrena, you might be a good candidate. Overall, this study is a chance to contribute to vital research while receiving close monitoring for any effects related to the medication.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All administered patients
- Exclusion Criteria:
- • Nothing
About Pfizer
Pfizer Inc. is a global leader in biopharmaceutical innovation, dedicated to discovering, developing, and delivering advanced therapies that enhance patient outcomes across a wide range of medical conditions. With a rich history of scientific research and a commitment to quality, Pfizer focuses on areas such as oncology, immunology, cardiology, and rare diseases. The company leverages cutting-edge technology and collaborates with healthcare professionals, regulatory bodies, and academic institutions to conduct rigorous clinical trials that ensure the safety and efficacy of its products. Pfizer's mission is to bring breakthroughs that change patients' lives, exemplifying its commitment to health and wellness worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tokyo, , Japan
Patients applied
Trial Officials
Pfizer CT.gov Call Center
Study Director
Pfizer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials